Menu

Jet Lag Upsets Gut Microbes

Frequent airplane travel may contribute to obesity by throwing off circadian rhythms and changing the composition of the intestinal microbiome, according to a new study.

Oct 17, 2014
Bob Grant

WIKIMEDIA, BOB SMITH, EPAJet lag may be as disorienting to the microbes that inhabit the human intestinal tract as it is to the human, according to a new study of how disturbances to the circadian clock can impact the gut microbiome. Researchers in Israel have shown, in both mice and humans, that the bacterial assemblages inhabiting the digestive tract are vulnerable to the ravages of circadian rhythm alterations. And when the gut microbiome is disrupted, they found, a suite of maladies, including glucose intolerance and obesity, result.

Immunologist Eran Elinav of the Weizmann Institute of Science in Rehovot led a team of researchers that subjected mice to a disruption in their sleep cycle that mimicked jet lag from an 8-hour time difference in humans and surveyed changes to their gut microbes. The researchers, who published their work in Cell on Wednesday (October 15), also studied the microbiota of two people who flew from the U.S. to Israel, and found similar compositional and functional changes. “We saw that in the presence of jet lag, their microbes were completely messed up,” Elinav told Time.

When Elinav and his colleagues transferred jet-lagged microbes from either mice or humans into germ-free mice, the rodents became more susceptible to glucose intolerance and diabetes. “We could very nicely see that transferring the gut microbes from the point where jet lag was at its highest induced much more obesity and glucose intolerance,” he said.

The human microbiomes that changed in response to jet lag did, however, return to normal two weeks after their flight. But frequent air travel or other activities that disrupt sleep/wake cycles, such as shift work, could make the disruptions, and their resultant health problems, chronic.

December 2019

Markers of Alzheimer’s

Hints about brain health can be found in the blood

Marketplace

Sponsored Product Updates

Chemyx: Navigating Legal and Regulatory Requirements for Cannabis Research and Product Development in the United States
Chemyx: Navigating Legal and Regulatory Requirements for Cannabis Research and Product Development in the United States
Given its legal status as a controlled substance, researchers, producers, and developers still must be aware of a considerable number of regulatory guidelines and practices governing the cannabis industry.
Chemyx: Cannabis Extraction on the Cutting Edge
Chemyx: Cannabis Extraction on the Cutting Edge
Tully Stroud, Chief Scientific Officer for Elite Molecular Labs, talks about the growing field of cannabis extraction and refinement. 
Heart-on-a-Chip Technology Predicts Preclinical Systolic and Diastolic in vivo Observations for Novel Cardiac Drug in Development
Heart-on-a-Chip Technology Predicts Preclinical Systolic and Diastolic in vivo Observations for Novel Cardiac Drug in Development
TARA Biosystems, Inc. today reported in vivo and in vitro functional data from a study of investigational candidate, MYK-491, showing that TARA’s human iPSC-derived organ-on-a-chip technology can directly measure in vivo cardiac performance.